文献速递产科母胎医学

产时发热峰值与持续时间对围产结局的影响

The impact of peak and duration of maternal intrapartum fever on perinatal outcomes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-05-10

该回顾性队列分析了两中心2003至2015年间85713例足月单胎活产,其中1517例(1.8%)产时发热(体温≥38.0°C)。研究发现新生儿不良复合结局随产妇最高体温升高呈剂量依赖性地逐渐恶化,最高体温与发热持续时间联合评估时亦呈类似剂量反应恶化(P=.015)。发热程度或持续时间与剖宫产或器械助产无独立关联(P=.648),仅持续时间与新生儿结局恶化无显著关联(P=.711)。

要点

  • 产妇产时最高体温越高,新生儿不良复合结局呈剂量依赖性恶化。
  • 最高体温联合发热持续时间评估时,新生儿结局亦呈剂量反应恶化(P=.015)。
  • 发热程度或持续时间与剖宫产或器械助产无独立关联(P=.648)。

核心结论

  • 产时产妇最高体温单独或联合发热持续时间,均与新生儿并发症呈剂量依赖性相关。
  • 需进一步前瞻性研究检验严格母体体温控制对围产结局的潜在获益。

研究设计与样本

  • 回顾性队列分析,纳入2个医疗中心2003至2015年间足月单胎活产。
  • 共分析85713例分娩,其中1517例(1.8%)产时发热(体温≥38.0°C)。
  • 发热持续时间定义为首次记录发热至随后首次记录正常体温(<38°C)或至分娩时体温未恢复正常的时间。
  • 采用多因素logistic回归模型校正混杂因素后计算不良围产结局的调整风险。

主要发现

  • 新生儿不良复合结局随产妇最高体温升高呈剂量反应性逐渐恶化。
  • 最高体温联合发热持续时间评估时,同样发现剂量反应性恶化(P=.015)。
  • 发热程度更高或持续时间更长与剖宫产或器械助产无独立关联(P=.648)。
  • 仅发热持续时间与新生儿结局恶化无显著关联(P=.711)。

临床怎么用

  • 临床应关注产时发热的峰值温度,其与新生儿不良结局呈剂量依赖性相关。
  • 评估产时发热风险时,可结合最高体温与发热持续时间综合判断新生儿结局风险。

局限性

  • 本研究为回顾性队列分析,可能存在残余混杂。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrapartum fever is a common perinatal complication, associated with short- and long-term adverse outcomes. Limited data exist regarding the association between the peak and duration of maternal fever and the extent and severity of maternal and neonatal complications. OBJECTIVE: This study aimed to examine the association between maternal intrapartum fever peak and duration and perinatal outcomes. STUDY DESIGN: A retrospective cohort analysis of term singleton live births in 2 medical centers between the years 2003 and 2015 was conducted. The study group included parturients who experienced intrapartum fever, defined as a temperature of ≥38.0°C (100.4°F). Fever duration was defined as the time elapsed between the first documented fever and subsequent first documented normal body temperature (<38°C or <100.4°F) or if the temperature did not return to normal until delivery. Adjusted risks for adverse perinatal outcomes were calculated using multiple logistic regression models to control for confounders. RESULTS: A cohort study of 85,713 deliveries was analyzed, of which 1517 (1.8%) parturients experienced fever during delivery. Adverse composite neonatal outcome gradually worsens, in a dose-response manner, with higher maximal maternal temperature. Similar dose-response deterioration was found when maximal parturient temperature was combined with fever duration (P=.015). Higher or longer maternal fever was not independently associated with cesarean or instrumental deliveries (P=.648). Duration alone was not significantly associated with worsening neonatal outcomes (P=.711). CONCLUSION: Maximal intrapartum maternal fever, solely and when combined with fever duration, is correlated with neonatal complications in a dose-dependent manner. Further prospective studies are needed to examine the potential benefit of rigorous maternal body temperature control on perinatal outcomes.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Hochler H, Lipschuetz M, Guedalia J, et al. The impact of peak and duration of maternal intrapartum fever on perinatal outcomes. Am J Obstet Gynecol MFM. 2021. PMID: 33984531. doi:10.1016/j.ajogmf.2021.100390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。